Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 2 , Pages 121-124, Summer 2009

Pathologic Evaluation of Malignant Pleural Mesothelioma

  • Lucian R. Chirieac, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Lucian R. Chirieac, MD, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA
  • ,
  • Joseph M. Corson, MD

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Pathologists play an important role in the surgical management of diffuse malignant pleural mesothelioma, which relies heavily on accurate diagnosis and staging. The pathologist provides crucial input to the determination of many prognostic factors including histologic subtype, extent of local disease progression, resection margins, and nodal status. They consult with the clinical care team at multiple points along the treatment spectrum, preoperatively, intraoperatively, and postoperatively. Finally, they are increasingly called on to guide selection of chemotherapy and measure treatment response.

Keywords: mesothelioma, immunohistochemistry, genetics, histology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1043-0679(09)00069-0

doi:10.1053/j.semtcvs.2009.06.005

Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 2 , Pages 121-124, Summer 2009